Arquilla E R, Packer S, Tarmas W, Miyamoto S
Endocrinology. 1978 Oct;103(4):1440-9. doi: 10.1210/endo-103-4-1440.
Experiments were designed to study the effect of Zn on in vivo and in vitro insulin metabolism. The in vivo experiments involved pretreating mice with either Zn or Na, followed by ip [125I]iodoinsulin injection. Pretreatment of mice with Zn resulted in an accelerated and increased magnitude of binding of [125I]iodoinsulin to the liver compared to mice pretreated with Na. Results are submitted which support the probability that the changes in the amounts of intact and degraded insulin in circulation with time are related to the binding and degradation of insulin in the liver rather than in the kidney. In vivo ip injected insulin was demonstrated to preferentially bind to the plasma membrane of the liver. Liver plasma membranes isolated from mice pretreated with Zn bound more [125I]iodoinsulin than plasma membranes of Na-pretreated mice. In vitro experiments employing isolated liver plasma membranes demonstrated that added Zn increased the binding and inhibited the degradation of insulin. Evidence is presented that supports the concept that two receptors exist, one at which degradation of [125I]iodoinsulin occurs and another at which degradation does not occur.
实验旨在研究锌对体内和体外胰岛素代谢的影响。体内实验包括用锌或钠预处理小鼠,然后腹腔注射[125I]碘胰岛素。与用钠预处理的小鼠相比,用锌预处理的小鼠导致[125I]碘胰岛素与肝脏的结合加速且结合量增加。提交的结果支持这样一种可能性,即循环中完整胰岛素和降解胰岛素的量随时间的变化与肝脏而非肾脏中胰岛素的结合和降解有关。体内腹腔注射的胰岛素被证明优先结合于肝脏的质膜。从用锌预处理的小鼠分离的肝质膜比用钠预处理的小鼠的质膜结合更多的[125I]碘胰岛素。使用分离的肝质膜的体外实验表明,添加锌会增加胰岛素的结合并抑制其降解。有证据支持存在两种受体的概念,一种是[125I]碘胰岛素发生降解的受体,另一种是不发生降解的受体。